Skip to main content

Backed by Clinical Research

Backed by a rigorous triple-blind, placebo-controlled study with adults aged 40-65, 

Remedolor demonstrated positive trends. 

In Week 8, participant agreement was higher for Remedolor versus the placebo.  68.97% of Remedolor users reported less back pain versus 59.62% of the placebo users. 

Healthy  Support

IL-6, a natural marker that can rise with joint discomfort, decreased by 2.31% with Remedolor, while placebo saw a 16.95% increase—supporting a balanced  response for happier joints. (IL-6 is a substance that increases with joint wear and tear; keeping it in check may promote comfort.)

Well Tolerated and Gentle

Well-tolerated with no consistent side effects in a 12-week study, making it a excellent choice for long-term use.

Testimonials

female, 60s

FP

“I am using less OTC pain killers and moving more freely.”

★★★★★

male, 60s

MT

– “After a few weeks, I found that I am less stiff, especially when getting to a
standing position.” ★★★★★